Antibiotice lasi Announces Earnings Results for the Nine Months of 2017
Antibiotice lasi announced earnings results for the nine months of 2017. For the nine months, the company’s sales revenues amounted to RON 234.2 million, by 4% higher than the estimate indicated in the Income and Expenditure Budget, and by 3% higher compared to the similar period of 2016, when the sales revenues amounted RON 227.3 million. Moreover, the net profit amounted to RON 20.24 million, by 37% higher than the value indicated in the Budget and by 14% higher than in the first nine months of 2016.